Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growing importance of MYC/BCL2 immunohistochemistry in diffuse large B-cell lymphomas.

× No keyword cloud information.

11 in total

1. Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China.

Authors: Jing Zhang; Jian Sun; Jun Feng; Yufeng Luo; Qing Ling; Shafei Wu; Xuan Zeng; Zhiyong Liang
Journal: Virchows Arch Date: 2018-05-25 Impact factor: 4.064

2. R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433.

Authors: Jonathan W Friedberg; Joseph M Unger; W Richard Burack; Ajay K Gopal; Robert N Raju; Auayporn P Nademanee; Mark S Kaminski; Hongli Li; Oliver W Press; Thomas P Miller; Richard I Fisher
Journal: Br J Haematol Date: 2014-04-18 Impact factor: 6.998

Review 3. The impact of MYC rearrangements and "double hit" abnormalities in diffuse large B-cell lymphoma.

Authors: Pei Lin; L Jeffrey Medeiros
Journal: Curr Hematol Malig Rep Date: 2013-09 Impact factor: 3.952

4. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Authors: Zijun Y Xu-Monette; Bouthaina S Dabaja; Xiaoxiao Wang; Meifeng Tu; Ganiraju C Manyam; Alexander Tzankov; Yi Xia; Li Zhang; Ruifang Sun; Carlo Visco; Karen Dybkaer; Lihui Yin; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Ben M Parsons; Xiaoying Zhao; Jane N Winter; Miguel A Piris; Timothy J McDonnell; Roberto N Miranda; Yong Li; L Jeffrey Medeiros; Ken H Young
Journal: Mod Pathol Date: 2015-11-06 Impact factor: 7.842

5. Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis.

Authors: Lu Li; Yanyan Li; Ximei Que; Xue Gao; Qian Gao; Mingxing Yu; Kaili Ma; Yanfeng Xi; Tong Wang
Journal: Sci Rep Date: 2018-04-19 Impact factor: 4.379

Review 6. C-MYC aberrations as prognostic factors in diffuse large B-cell lymphoma: a meta-analysis of epidemiological studies.

Authors: Kuangguo Zhou; Danmei Xu; Yang Cao; Jue Wang; Yunfan Yang; Mei Huang
Journal: PLoS One Date: 2014-04-16 Impact factor: 3.240

7. Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2.

Authors: Daruka Mahadevan; Carla Morales; Laurence S Cooke; Ann Manziello; David W Mount; Daniel O Persky; Richard I Fisher; Thomas P Miller; Wenqing Qi
Journal: PLoS One Date: 2014-06-03 Impact factor: 3.240

8. MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.

Authors: Li-Xu Yan; Yan-Hui Liu; Dong-Lan Luo; Fen Zhang; Yu Cheng; Xin-Lan Luo; Jie Xu; Jie Cheng; Heng-Guo Zhuang
Journal: PLoS One Date: 2014-08-04 Impact factor: 3.240

9. New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse Large B-Cell Lymphoma.

Authors: Gilbert Bigras; Wei-Feng Dong; Sarah Canil; Raymond Lai; Didier Morel; Paul E Swanson; Iyare Izevbaye
Journal: Appl Immunohistochem Mol Morphol Date: 2018-01

10. C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases.

Authors: Dayang Sharyati Datu Abdul Salam; Ei Ei Thit; Siew Hoon Teoh; Soo Yong Tan; Suat Cheng Peh; Shiau-Chuen Cheah
Journal: J Cancer Date: 2020-01-01 Impact factor: 4.207